J&J sees AI halving the time to generate drug development leads

Scroll

Johnson Johnson is using the new technology to screen the 'potential universe' for promising chemical compounds or biologics, CIO Jim Swanson says

Coverage and analysis from Philippines. All insights are generated by our AI narrative analysis engine.

Philippines

Bias: lean left

0/500

Note: Comments are moderated. Please keep it civil. Max 3 comments per day.

No recent articles found in this language.